Literature DB >> 2984649

Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.

A B Atkinson, A L Kennedy, B Sheridan.   

Abstract

A patient with ACTH-dependent Cushing's syndrome remained in clinical and biochemical remission six years after pituitary irradiation and while on bromocriptine therapy. When bromocriptine was discontinued urinary free cortisol values became elevated, and were not suppressed by dexamethasone. After reintroduction of the drug, remission was again obtained. It is concluded that bromocriptine is responsible for continuing longterm remission in this case. The possible use of bromocriptine as an adjunctive therapy in ACTH-dependent Cushing's syndrome is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984649      PMCID: PMC2418213          DOI: 10.1136/pgmj.61.713.239

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.

Authors:  B Ambrosi; M Gaggini; F Secchi; G Faglia
Journal:  Horm Metab Res       Date:  1979-04       Impact factor: 2.936

3.  The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy.

Authors:  S W Lamberts; H A Timmermans; F H De Jong; J C Birkenhager
Journal:  Clin Endocrinol (Oxf)       Date:  1977-09       Impact factor: 3.478

4.  Effect of bromocriptine in pituitary-dependent Cushing's syndrome.

Authors:  S W Lamberts; J C Birkenhäger
Journal:  J Endocrinol       Date:  1976-08       Impact factor: 4.286

5.  ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.

Authors:  A L Kennedy; B Sheridan; D A Montgomery
Journal:  Acta Endocrinol (Copenh)       Date:  1978-11

6.  A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique.

Authors:  D Riad-Fahmy; G F Read; S J Gaskell; J Dyas; R Hindawi
Journal:  Clin Chem       Date:  1979-05       Impact factor: 8.327

7.  Spontaneous remission of Cushing's disease. Report of a case.

Authors:  J P Hayslett; G L Cohn
Journal:  N Engl J Med       Date:  1967-04-27       Impact factor: 91.245

8.  Cyproheptadine-induced remission of Cushing's disease.

Authors:  D T Krieger; L Amorosa; F Linick
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

9.  Bromocriptine and endocrine disorders.

Authors:  R F Spark; G Dickstein
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

10.  DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate.

Authors:  C Davies; J Jacobi; H M Lloyd; J D Meares
Journal:  J Endocrinol       Date:  1974-06       Impact factor: 4.286

View more
  2 in total

1.  Dopamine D2 receptor gene expression in human adenohypophysial adenomas.

Authors:  L Stefaneanu; K Kovacs; E Horvath; M Buchfelder; R Fahlbusch; L Lancranjan
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 2.  Role of "old" pharmacological agents in the treatment of Cushing's syndrome.

Authors:  A G Ambrogio; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2016-04-16       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.